MIMS Education

Diagnostics and Therapeutics for Alzheimer’s Disease

Diagnostics and Therapeutics for Alzheimer’s Disease

Internal MedicineFamily MedicineGeneral PracticeGeriatric Medicine
A badge with ribbon in color black CME Unit: 1 Point | An analog clock in color black 1 hour | A black calendar with white triangle in center that has a black exclamation point in the middle 02 Dec 2022 


About this course

Alzheimer’s disease (AD) is the most common cause of dementia with the global prevalence rapidly increasing over the decades. Early screening, diagnosis and appropriate management is important to ensure better quality of life for the patients and their families. This e-learning module summarizes the pathophysiology, etiology, clinical manifestations, screening, diagnosis, and current and emerging treatment options for AD.

Learning outcomes

Upon completion of the educational activity, health care providers should be able to
  • Understand epidemiology and disease burden of AD
  • Recognize risk factors
  • Discover emerging techniques of diagnosis and treatment

Topics covered

  • Characteristics of AD: causes, risk factors, pathophysiology
  • Clinical manifestations of AD
  • Importance of early diagnosis and treatment
  • Screening and diagnosis of AD
  • Current and emerging therapeutics for AD

1 CME Point Available

  • This module is accredited for 1 CME Point for medical practitioners enrolled in The Medical Council of Hong Kong’s Continuing Medical Education Programme for Practising Doctors who are not taking CME for Specialists.
  • This module is accredited for 1 CME Point for fellows of the Hong Kong College of Physicians.
  • Please note that this module will not earn CME credit for fellows of colleges not listed here.
  • A certificate can be downloaded upon successful completion of the quiz. Please use the information on the certificate to claim your CME points.

Reviewed and endorsed by